Leadinno Snags over CNY 100 Mn in Series A Financing Round

Leadinno Medical Valley recently announced its completion of a Series A financing round worth more than CNY 100 million. 

This round was led by Proxima Venture Capital and the existing investor Med-Fine Capital. TigerYeah Capital, Meihong Investment and the existing investor Cowin Captial also participated in this deal. Genesis Partners acted as the financial advisor. 

The proceeds will be used for product R&D and manufacturing of Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulator (PNS), team expansion and company operation. 

Founded in 2016, Leadinno is a neuroregulatory medical device developer in China with innovative wireless implantable nerve stimulation technology platform as the breakthrough point. It focuses on the R&D and promotion of innovative technologies in the field of pain management and neuroregulation. Professor Han Jisheng, the Director of the Neuroscience Research Institute, and Professor Fan Bifa, the academic leader of pain R&D in China, are the chief scientists of Leadinno Medical Valley.